Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742820 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
A Phase 1 study, sponsored by Fresenius Medical Care North America.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT00742820: Completed Phase 1 study, sponsored by Fresenius Medical Care North America.
NCT00742820 is a Phase 1 study that has completed, run by Fresenius Medical Care North America. The registered enrollment target is 46 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00742820, a Phase 1 study, has completed, sponsored by Fresenius Medical Care North America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
To compare the bioequivalence of calcium acetate oral solution vs. calcium acetate gelcaps in healthy volunteers with calcium citrate as a positive control.
Interventions
- DRUG Calcium Acetate Oral Solution 667 mg per 5 mL
- DRUG Calcium Acetate 667 mg GelCaps
- DIETARY_SUPPLEMENT Calcium Citrate 950 mg Caplets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
What the finished NCT00742820 record still lists
NCT00742820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 3 interventions - of which Calcium Acetate Oral Solution 667 mg per 5 mL is the first listed.
NCT00742820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00742820 about?
NCT00742820 is a clinical study titled "Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers". To compare the bioequivalence of calcium acetate oral solution vs. calcium acetate gelcaps in healthy volunteers with calcium citrate as a positive control.
What is the current status of trial NCT00742820?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2008-08. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00742820?
The interventions under investigation include: Calcium Acetate Oral Solution 667 mg per 5 mL (DRUG), Calcium Acetate 667 mg GelCaps (DRUG), Calcium Citrate 950 mg Caplets (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00742820?
This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00742820's enrollment target sits among peer trials
46 1058th of 2000 higher than 935 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia